Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis

BACKGROUND: The brain is a common metastatic site in patients with non-small cell lung cancer (NSCLC), resulting in a relatively poor prognosis. Systemic therapy with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is recommended as the first-line treatment for EGFR-mutated...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yixiang, Liu, Chengcheng, Xu, Ziyi, Zou, Zihua, Xie, Tongji, Xing, Puyuan, Wang, Le, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617931/
https://www.ncbi.nlm.nih.gov/pubmed/37160733
http://dx.doi.org/10.1097/CM9.0000000000002468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617931/
https://www.ncbi.nlm.nih.gov/pubmed/37160733
http://dx.doi.org/10.1097/CM9.0000000000002468

Ejemplares similares